Added to cart

Serenol is a non-prescription option that contains ingredients clinically shown to relieve emotional and some physical symptoms of PMS.*

In a study, ingredients in Serenol were shown to significantly reduce irritability and dysphoria.*†‡ Dysphoria is a feeling of general uneasiness or dissatisfaction. Discover more about how the ingredients in Serenol can help you get back to feeling like yourself again.

Serenol is made of flower pollen extract, royal jelly, and Chromax® chromium picolinate

What is Serenol?

One ingredient in Serenol is a naturally occurring, highly purified Swedish flower pollen extract. This pollen extract is endorsed by gynecologists and has been used in Europe for over 15 years.

Royal jelly is another ingredient in Serenol that was tested along with the Swedish flower pollen extract.

Serenol also contains Chromax® chromium picolinate, which helps the insulin in your body work efficiently to process sugar and reduce food cravings and intake.*

Serenol was specially made to treat the emotional symptoms of PMS, particularly irritability and/or mood fluctuations

The main ingredient in Serenol is pollen extract taken from flowers that are grown in Sweden. It is grown in a pesticide-free environment. Serenol's manufacturing process removes the allergenic husk of the pollen to increase bioavailability. Serenol is also made from royal jelly, a milky secretion made from bees.

Serenol is manufactured in the US using the Swedish flower pollen extract and Chromax® chromium picolinate according to current Good Manufacturing Practices (cGMP).

Serenol does not contain gluten or soy. The manufacturing process used to purify the Swedish pollen extract used in Serenol removes a significant percentage of pollen allergens. Serenol contains royal jelly, an ingredient made from bees. You should not take Serenol if you are allergic to bees or bee products. If you are concerned, please consult your medical professional.

† Emotional symptoms results based on published, 4-month, double-blind, placebo-controlled clinical trial: Winther K, Hedman C. Curr Ther Res Clin Exp. 2002;63(5):344-353. Physical symptoms results based on various doubl-blind, placebo-controlled clinical trials: Winther K, Hedman C. Curr Ther Res Clin Exp. 2002;63(5):344-353, Gerhardsen G, et al. Adv Ther.2008;25(6):595-607, and Anton S, et al. Diabetes Technol Ther. 2008;10(5): 405-412.

‡ Based on data from a published, 4-month, double-blind, placebo-controlled clincial trial.